Nalu Bio, Inc. — Form D
Nalu Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-03. The offering totals $17.1M, of which $4.8M was reported sold. Industry: Other.
Offering
- Filed: 2023-03-03
- Form: D
- Accession: 0001966319-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $17.1M
- Amount sold: $4.8M
- Remaining: $12.3M
- Investors: 11
- Date of first sale: 2023-01-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-474858
Issuer
- Name: Nalu Bio, Inc.
- CIK: 0001966319
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 38 KEYES AVENUE, SUITE 200, SAN FRANCISCO, CA, 94129
- Phone: (415) 706-0623
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Howard E Goodwin | Director | San Francisco, CA |
| Caitlyn Krebs | Director | San Francisco, CA |
| Randall S Ussery | Director | San Francisco, CA |
| Phyllis E Whiteley | Director | San Francisco, CA |
| Caitlyn Krebs | Executive Officer | San Francisco, CA |
| Phyllis E Whiteley | Executive Officer | San Francisco, CA |
More